Condition: Type 2 Diabetes · Sponsor: University of New Brunswick
The goal of this trial is to learn if blood flow restriction training with treadmill walking is possible for individuals living with type 2 diabetes. It will also learn about how the blood flow restriction with treadmill walking could improve health. The main questions it aims to answer are: Is 6 weeks of treadmill walking with blood flow restriction reasonable for people with type 2 diabetes to perform? Does treadmill walking with blood flow restriction training help manage type 2 diabetes better than just treadmill walking? Researchers will compare treadmill walking with blood flow restriction to treadmill walking without blood flow restriction to see if blood flow restriction works to manage type 2 diabetes based on fitness and blood sugar levels. Participants will: Perform treadmill walking with or without blood flow restriction for 96 minutes a week for 6 weeks. Visit the lab before and after the exercise for tests and questionnaires.
This description comes directly from the study's public registry record.
Martin Senechal, PhD · 506-451-6889 · martin.senechal@unb.ca
Jamie Burr, PhD · 519-824-4120 · burrj@uoguelph.ca
Always discuss trial participation with your own doctor first.
| Exercise Metabolism and Inflammation Laboratory | Okanagan, British Columbia, Canada | Not Yet Recruiting |
| Cardiometabolic Exercise & Lifestyle Laboratory | Fredericton, New Brunswick, Canada | Recruiting |
| Human Performance & Health Research Laboratory | Guelph, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07196371